Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Five-year outcomes of patients with diabetes mellitus treated with a sirolimus-eluting or a biolimus-eluting stents with biodegradable polymer. From the SORT OUT VII trial.
Trøan J, Christiansen EH, Hansen KN, Eftekhari A, Jakobsen L, Mæng M, Freeman P, Jensen RV, Christensen MK, Noori M, Ellert-Gregersen J, Støttrup NB, Kahlert J, Veien KT, Jensen LO. Trøan J, et al. Among authors: ellert gregersen j. Diab Vasc Dis Res. 2024 Sep-Oct;21(5):14791641241283939. doi: 10.1177/14791641241283939. Diab Vasc Dis Res. 2024. PMID: 39311502 Free PMC article. Clinical Trial.
Optimal lesion preparation before implantation of a Magmaris bioresorbable scaffold in patients with coronary artery stenosis: Rationale, design and methodology of the OPTIMIS study.
Hansen KN, Maehara A, Noori M, Trøan J, Fallesen CO, Hougaard M, Ellert-Gregersen J, Veien KT, Junker A, Hansen HS, Lassen JF, Jensen LO. Hansen KN, et al. Among authors: ellert gregersen j. Contemp Clin Trials Commun. 2024 Feb 7;38:101260. doi: 10.1016/j.conctc.2024.101260. eCollection 2024 Apr. Contemp Clin Trials Commun. 2024. PMID: 38384894 Free PMC article.
Long-term outcomes after coronary intervention with biodegradable polymer stents in patients with acute coronary syndromes.
Noori M, Christiansen EH, Raungaard B, Junker A, Christensen MK, Kahlert J, Maeng M, Freeman P, Hansen KN, Terkelsen CJ, Ellert-Gregersen J, Kristensen SD, Veien KT, Jakobsen L, Jensen LO. Noori M, et al. Among authors: ellert gregersen j. Catheter Cardiovasc Interv. 2024 Feb;103(2):276-285. doi: 10.1002/ccd.30937. Epub 2023 Dec 13. Catheter Cardiovasc Interv. 2024. PMID: 38091338 Clinical Trial.
Outcomes and performance of the ACURATE neo2 transcatheter heart valve in clinical practice: one-yearresults of the ACURATE neo2 PMCF Study.
Kim WK, Möllmann H, Montorfano M, Ellert-Gregersen J, Rudolph TK, Van Mieghem NM, Hilker M, Amat-Santos I, Terkelsen CJ, Petronio AS, Stella P, Götberg M, Rück A, Kasel AM, Trillo R, Appleby C, Barbanti M, Blanke P, Asch FM, Modolo R, Allocco DJ, Tamburino C. Kim WK, et al. Among authors: ellert gregersen j. EuroIntervention. 2024 Jan 1;20(1):85-94. doi: 10.4244/EIJ-D-23-00823. EuroIntervention. 2024. PMID: 37982152 Free PMC article.
Five-Year Clinical Outcome of the Biodegradable Polymer Ultrathin Strut Sirolimus-Eluting Stent Compared to the Biodegradable Polymer Biolimus-Eluting Stent in Patients Treated With Percutaneous Coronary Intervention: From the SORT OUT VII Trial.
Hansen KN, Jensen LO, Maeng M, Christensen MK, Noori M, Kahlert J, Jakobsen L, Junker A, Freeman P, Ellert-Gregersen J, Raungaard B, Terkelsen CJ, Veien KT, Christiansen EH. Hansen KN, et al. Among authors: ellert gregersen j. Circ Cardiovasc Interv. 2023 Jan;16(1):e012332. doi: 10.1161/CIRCINTERVENTIONS.122.012332. Epub 2023 Jan 17. Circ Cardiovasc Interv. 2023. PMID: 36649389 Clinical Trial.
Clinical outcomes of the ACURATE neo2 transcatheter heart valve: a prospective, multicenter, observational, post-market surveillance study.
Kim WK, Tamburino C, Möllmann H, Montorfano M, Ellert-Gregersen J, Rudolph TK, Van Mieghem NM, Hilker M, Amat-Santos IJ, Terkelsen CJ, Petronio AS, Stella PR, Götberg M, Rück A, Kasel AM, Trillo R, Appleby C, Barbanti M, Blanke P, Modolo R, Allocco DJ, Sondergaard L. Kim WK, et al. Among authors: ellert gregersen j. EuroIntervention. 2022 Nov 27;19(1):83-92. doi: 10.4244/EIJ-D-22-00914. Online ahead of print. EuroIntervention. 2022. PMID: 36440588 Free PMC article.
Impact of diabetes on 1-year clinical outcome in patients undergoing revascularization with the BioFreedom stents or the Orsiro stents from the SORT OUT IX trial.
Hansen KN, Maeng M, Raungaard B, Engstrøm T, Veien KT, Kristensen SD, Ellert-Gregersen J, Jensen SE, Junker A, Kahlert J, Jakobsen L, Christiansen EH, Jensen LO. Hansen KN, et al. Among authors: ellert gregersen j. Catheter Cardiovasc Interv. 2022 Mar;99(4):1095-1103. doi: 10.1002/ccd.30090. Epub 2022 Jan 18. Catheter Cardiovasc Interv. 2022. PMID: 35043539 Clinical Trial.
Polymer-free biolimus-coated stents versus ultrathin-strut biodegradable polymer sirolimus-eluting stents: two-year outcomes of the randomised SORT OUT IX trial.
Ellert-Gregersen J, Jensen LO, Jakobsen L, Freeman PM, Eftekhari A, Maeng M, Raungaard B, Engstroem T, Kahlert J, Hansen HS, Christiansen EH. Ellert-Gregersen J, et al. EuroIntervention. 2022 Jun 3;18(2):e124-e131. doi: 10.4244/EIJ-D-21-00874. EuroIntervention. 2022. PMID: 34984983 Free PMC article. Clinical Trial.